- Home
- OTRK vs SNGX Comparison
OTRK vs SNGX Comparison
Compare OTRK & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTRK
- SNGX
- Stock Information
- Founded
- OTRK 2003
- SNGX 1987
- Country
- OTRK United States
- SNGX United States
- Employees
- OTRK N/A
- SNGX N/A
- Industry
- OTRK Misc Health and Biotechnology Services
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- OTRK Health Care
- SNGX Health Care
- Exchange
- OTRK Nasdaq
- SNGX Nasdaq
- Market Cap
- OTRK 6.1M
- SNGX 6.5M
- IPO Year
- OTRK N/A
- SNGX 1987
- Fundamental
- Price
- OTRK $1.53
- SNGX $1.93
- Analyst Decision
- OTRK Strong Buy
- SNGX
- Analyst Count
- OTRK 1
- SNGX 0
- Target Price
- OTRK $45.00
- SNGX N/A
- AVG Volume (30 Days)
- OTRK 28.3K
- SNGX 18.4K
- Earning Date
- OTRK 05-20-2025
- SNGX 05-09-2025
- Dividend Yield
- OTRK N/A
- SNGX N/A
- EPS Growth
- OTRK N/A
- SNGX N/A
- EPS
- OTRK N/A
- SNGX N/A
- Revenue
- OTRK $10,183,000.00
- SNGX $2,342.00
- Revenue This Year
- OTRK $50.12
- SNGX N/A
- Revenue Next Year
- OTRK $55.26
- SNGX N/A
- P/E Ratio
- OTRK N/A
- SNGX N/A
- Revenue Growth
- OTRK N/A
- SNGX N/A
- 52 Week Low
- OTRK $1.27
- SNGX $1.68
- 52 Week High
- OTRK $5.53
- SNGX $14.83
- Technical
- Relative Strength Index (RSI)
- OTRK 49.62
- SNGX 49.95
- Support Level
- OTRK $1.43
- SNGX $1.86
- Resistance Level
- OTRK $1.55
- SNGX $1.97
- Average True Range (ATR)
- OTRK 0.10
- SNGX 0.09
- MACD
- OTRK -0.01
- SNGX 0.01
- Stochastic Oscillator
- OTRK 44.44
- SNGX 70.59
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The group provides a value-based behavioral healthcare company that identifies and engages people with unmet health needs using the proprietary Advanced Engagement System to improve clinical outcomes and reduce total cost of care. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).